Post by icemandios on Sept 18, 2019 1:09:28 GMT
On 9/13/19, Director Sobecki bought 99,249 with prices ranging from 2.25-2.48. And on 9/16/19, he bought 25K with prices ranging 2.38-2.73. This brings his directly owned count to 137,293 shares.
On 9/13/19, Director Debbane bought 197,473 with prices ranging 2.25-2.455. And on 9/13 and 9/16/19, he bought 103,042 with prices ranging 2.46-2.80. This brings his directly owned count to 313,417 shares.
Debbane also reports indirectly owning 4,321,214 shares by Invus C.V.
As to Invus:
As of June 1, 2018, Invus C.V. was the record and beneficial owner of 4,321,214 shares of Issuer Common Stock, representing approximately 4.1% of the outstanding shares of Issuer Common Stock.
Ulys, L.L.C., as the general partner of Invus C.V., controls Invus C.V. and, accordingly, may be deemed to beneficially own the shares of Issuer Common Stock held by Invus C.V. Ulys, L.L.C. disclaims such beneficial ownership. As the sole member of Ulys, L.L.C., Mr. Raymond Debbane controls Ulys, L.L.C. and, accordingly, may be deemed to beneficially own the shares of Issuer Common Stock that Ulys, L.L.C. may be deemed to beneficially own. Mr. Debbane disclaims such beneficial ownership.
As of June 1, 2018, Mr. Debbane individually beneficially owns 12,902 shares of Issuer Common Stock and 22,140 shares of Issuer Common Stock issuable pursuant to options that are exercisable within 60 days of June 1, 2018.
As of June 1, 2018, collectively, the Reporting Persons beneficially owned 63,358,962 shares of Issuer Common Stock, representing approximately 59.9% of the outstanding shares of Issuer Common Stock.
Except for Messrs. Amouyal, Debbane, Guimarães, Minne and Sobecki, none of the individuals listed in Item 2 or Schedule I of the Statement beneficially owns any shares of Issuer Common Stock. Mr. Amouyal beneficially owns 12,902 shares of Issuer Common Stock and 22,140 shares of Issuer Common Stock issuable pursuant to options that are exercisable within 60 days of June 1, 2018. Mr. Guimarães beneficially owns 714 shares of Issuer Common Stock. Mr. Sobecki beneficially owns 13,044 shares of Issuer Common Stock and 22,140 shares of Issuer Common Stock issuable pursuant to options that are exercisable within 60 days of June 1, 2018. For each of Messrs. Amouyal, Guimarães and Sobecki, shares of Issuer Common Stock beneficially owned by them represent less than 1% of the number of outstanding shares of Issuer Common Stock.
(c) Except as set forth below or as otherwise described in the Statement, there have been no transactions in shares of Issuer Common Stock by any of the Reporting Persons or by any individuals or entities named in Item 2 of the Statement in the past 60 days. On April 27, 2018, each of Messrs. Amouyal, Debbane and Sobecki received a grant of 2,564 shares of Issuer Common Stock as compensation for his service as a member of the Issuer’s board of directors.
Ulys, L.L.C., as the general partner of Invus C.V., controls Invus C.V. and, accordingly, may be deemed to beneficially own the shares of Issuer Common Stock held by Invus C.V. Ulys, L.L.C. disclaims such beneficial ownership. As the sole member of Ulys, L.L.C., Mr. Raymond Debbane controls Ulys, L.L.C. and, accordingly, may be deemed to beneficially own the shares of Issuer Common Stock that Ulys, L.L.C. may be deemed to beneficially own. Mr. Debbane disclaims such beneficial ownership.
As of June 1, 2018, Mr. Debbane individually beneficially owns 12,902 shares of Issuer Common Stock and 22,140 shares of Issuer Common Stock issuable pursuant to options that are exercisable within 60 days of June 1, 2018.
As of June 1, 2018, collectively, the Reporting Persons beneficially owned 63,358,962 shares of Issuer Common Stock, representing approximately 59.9% of the outstanding shares of Issuer Common Stock.
Except for Messrs. Amouyal, Debbane, Guimarães, Minne and Sobecki, none of the individuals listed in Item 2 or Schedule I of the Statement beneficially owns any shares of Issuer Common Stock. Mr. Amouyal beneficially owns 12,902 shares of Issuer Common Stock and 22,140 shares of Issuer Common Stock issuable pursuant to options that are exercisable within 60 days of June 1, 2018. Mr. Guimarães beneficially owns 714 shares of Issuer Common Stock. Mr. Sobecki beneficially owns 13,044 shares of Issuer Common Stock and 22,140 shares of Issuer Common Stock issuable pursuant to options that are exercisable within 60 days of June 1, 2018. For each of Messrs. Amouyal, Guimarães and Sobecki, shares of Issuer Common Stock beneficially owned by them represent less than 1% of the number of outstanding shares of Issuer Common Stock.
(c) Except as set forth below or as otherwise described in the Statement, there have been no transactions in shares of Issuer Common Stock by any of the Reporting Persons or by any individuals or entities named in Item 2 of the Statement in the past 60 days. On April 27, 2018, each of Messrs. Amouyal, Debbane and Sobecki received a grant of 2,564 shares of Issuer Common Stock as compensation for his service as a member of the Issuer’s board of directors.